These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33882314)

  • 21. Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids.
    Bustamante-Madrid P; Barbáchano A; Albandea-Rodríguez D; Rodríguez-Cobos J; Rodríguez-Salas N; Prieto I; Burgos A; Martínez de Villarreal J; Real FX; González-Sancho JM; Larriba MJ; Lafarga M; Muñoz A; Fernández-Barral A
    Cell Death Dis; 2024 Apr; 15(4):301. PubMed ID: 38684650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids.
    Zhao Y; Li ZX; Zhu YJ; Fu J; Zhao XF; Zhang YN; Wang S; Wu JM; Wang KT; Wu R; Sui CJ; Shen SY; Wu X; Wang HY; Gao D; Chen L
    Adv Sci (Weinh); 2021 Jun; 8(11):e2003897. PubMed ID: 34105295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition.
    Zhao N; Powell RT; Yuan X; Bae G; Roarty KP; Stossi F; Strempfl M; Toneff MJ; Johnson HL; Mani SA; Jones P; Stephan CC; Rosen JM
    Nat Commun; 2021 Jul; 12(1):4262. PubMed ID: 34253738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture.
    Elbadawy M; Usui T; Mori T; Tsunedomi R; Hazama S; Nabeta R; Uchide T; Fukushima R; Yoshida T; Shibutani M; Tanaka T; Masuda S; Okada R; Ichikawa R; Omatsu T; Mizutani T; Katayama Y; Noguchi S; Iwai S; Nakagawa T; Shinohara Y; Kaneda M; Yamawaki H; Sasaki K
    Cancer Sci; 2019 Sep; 110(9):2806-2821. PubMed ID: 31254429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling colorectal cancer as a 3-dimensional disease in a dish: the case for drug screening using organoids, zebrafish, and fruit flies.
    Markstein M
    Drug Discov Today Technol; 2013; 10(1):e73-81. PubMed ID: 24050233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing.
    Crespo M; Vilar E; Tsai SY; Chang K; Amin S; Srinivasan T; Zhang T; Pipalia NH; Chen HJ; Witherspoon M; Gordillo M; Xiang JZ; Maxfield FR; Lipkin S; Evans T; Chen S
    Nat Med; 2017 Jul; 23(7):878-884. PubMed ID: 28628110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids.
    Tan T; Mouradov D; Gibbs P; Sieber OM
    STAR Protoc; 2024 Jun; 5(2):103090. PubMed ID: 38809757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput screening in colorectal cancer tissue-originated spheroids.
    Kondo J; Ekawa T; Endo H; Yamazaki K; Tanaka N; Kukita Y; Okuyama H; Okami J; Imamura F; Ohue M; Kato K; Nomura T; Kohara A; Mori S; Dan S; Inoue M
    Cancer Sci; 2019 Jan; 110(1):345-355. PubMed ID: 30343529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long Noncoding RNA H19 Impairs the Intestinal Barrier by Suppressing Autophagy and Lowering Paneth and Goblet Cell Function.
    Yu TX; Chung HK; Xiao L; Piao JJ; Lan S; Jaladanki SK; Turner DJ; Raufman JP; Gorospe M; Wang JY
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):611-625. PubMed ID: 31862317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiated cancer cell-originated lactate promotes the self-renewal of cancer stem cells in patient-derived colorectal cancer organoids.
    Zhao H; Yan C; Hu Y; Mu L; Liu S; Huang K; Li Q; Li X; Tao D; Qin J
    Cancer Lett; 2020 Nov; 493():236-244. PubMed ID: 32898601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
    Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.
    Saito Y; Muramatsu T; Kanai Y; Ojima H; Sukeda A; Hiraoka N; Arai E; Sugiyama Y; Matsuzaki J; Uchida R; Yoshikawa N; Furukawa R; Saito H
    Cell Rep; 2019 Apr; 27(4):1265-1276.e4. PubMed ID: 31018139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Analysis of Patient-Matched PDOs Revealed a Reduction in OLFM4-Associated Clusters in Metastatic Lesions in Colorectal Cancer.
    Okamoto T; duVerle D; Yaginuma K; Natsume Y; Yamanaka H; Kusama D; Fukuda M; Yamamoto M; Perraudeau F; Srivastava U; Kashima Y; Suzuki A; Kuze Y; Takahashi Y; Ueno M; Sakai Y; Noda T; Tsuda K; Suzuki Y; Nagayama S; Yao R
    Stem Cell Reports; 2021 Apr; 16(4):954-967. PubMed ID: 33711267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic evaluation of colorectal cancer organoid system by single-cell RNA-Seq analysis.
    Wang R; Mao Y; Wang W; Zhou X; Wang W; Gao S; Li J; Wen L; Fu W; Tang F
    Genome Biol; 2022 Apr; 23(1):106. PubMed ID: 35484598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer stem cells as a target population for drug discovery.
    Bouvard C; Barefield C; Zhu S
    Future Med Chem; 2014 Sep; 6(14):1567-85. PubMed ID: 25367391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protocol for isolation and functional validation of label-retaining quiescent colorectal cancer stem cells from patient-derived organoids for RNA-seq.
    Regan JL
    STAR Protoc; 2022 Mar; 3(1):101225. PubMed ID: 35300001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening.
    Verissimo CS; Overmeer RM; Ponsioen B; Drost J; Mertens S; Verlaan-Klink I; Gerwen BV; van der Ven M; Wetering MV; Egan DA; Bernards R; Clevers H; Bos JL; Snippert HJ
    Elife; 2016 Nov; 5():. PubMed ID: 27845624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells.
    Jaeckel S; Kaller M; Jackstadt R; Götz U; Müller S; Boos S; Horst D; Jung P; Hermeking H
    Nat Commun; 2018 Sep; 9(1):3573. PubMed ID: 30177706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KHDRBS3 promotes multi-drug resistance and anchorage-independent growth in colorectal cancer.
    Ukai S; Sakamoto N; Taniyama D; Harada K; Honma R; Maruyama R; Naka K; Hinoi T; Takakura Y; Shimizu W; Ohdan H; Yasui W
    Cancer Sci; 2021 Mar; 112(3):1196-1208. PubMed ID: 33423358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.